EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

An Innovative Phyto-Supplement Approach for Breast Cancer Supportive Care: Bioresonance-Based Screening Protocol

Helena Machado, Jorge Machado, Lara Lopes, Maria Ceu Monteiro, Maria Begoña Criado

Nutraceuticals · 09.11.2026 · 6 (4) · 72

DOI: 10.3390/nutraceuticals6040072 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Nutraceuticals, online erschienen am 09.11.2026. Verfasst von Helena Machado und 4 weiteren Autor:innen. Die Arbeit nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer is the most common malignancy among women worldwide and a leading cause of cancer-related mortality. Despite advances in surgery, chemotherapy, and radiotherapy, complementary therapies—particularly phytotherapy and nutritional interventions—are increasingly used, although their efficacy and safety remain insufficiently validated. Therefore, high-quality scientific evidence is still required to substantiate the use of these approaches.

Objective

Based on a comprehensive theoretical review, this study proposes a flexible and integrative research protocol—conceived as an adaptable methodological framework rather than a single fixed trial—to evaluate traditional phytopharmaceutical formulations used in breast cancer, combining molecular, cellular, animal, and clinical approaches with an exploratory bioresonance-based functional screening component.

Methods

The protocol integrates device-based exploratory assessment, in vitro, in vivo and clinical modules, providing a multiscale framework to investigate the efficacy, safety, and mechanisms of action of phytotherapeutic interventions. Bioresonance-based measurements are included strictly as exploratory, hypothesis-generating observations, to be cross-validated against established pharmacological, biochemical and clinical endpoints. Expected outcomes: The proposed protocol is expected to combine detailed molecular characterization, functional biological assays and patient-centered clinical monitoring. By integrating preclinical and clinical modules, the framework is intended to support the development of personalized therapeutic strategies and to define how exploratory device-based functional screening can be rigorously evaluated within conventional research pipelines.

Conclusions

Overall, this framework may contribute to generating structured evidence on phytotherapeutic strategies and to inform their possible future integration into personalized breast cancer care, provided that its exploratory components are independently validated.

Zitieren

APA

Machado, H., Machado, J., Lopes, L., Monteiro, M. C., & Criado, M. B. (2026). An Innovative Phyto-Supplement Approach for Breast Cancer Supportive Care: Bioresonance-Based Screening Protocol. Nutraceuticals, 6(4), 72. https://doi.org/10.3390/nutraceuticals6040072

Vancouver

Machado H, Machado J, Lopes L, Monteiro MC, Criado MB. An Innovative Phyto-Supplement Approach for Breast Cancer Supportive Care: Bioresonance-Based Screening Protocol. Nutraceuticals. 2026;6(4):72. doi:10.3390/nutraceuticals6040072

BibTeX
@article{Machado2026,
  author = {Machado, Helena and Machado, Jorge and Lopes, Lara and Monteiro, Maria Ceu and Criado, Maria Begoña},
  title = {An Innovative Phyto-Supplement Approach for Breast Cancer Supportive Care: Bioresonance-Based Screening Protocol},
  journal = {Nutraceuticals},
  year = {2026},
  volume = {6},
  number = {4},
  pages = {72},
  doi = {10.3390/nutraceuticals6040072}
}
Kostenlos starten →